Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/b34baee9-2ef9-43aa-be22-0e084e0f3c2a/

AIDX

20/20 Biolabs, Inc. Common Stock
Chart
$0.80
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.74
OS Score
61.0%
Value
61.0%
Quality
61.0%
Momentum
2/9
F-Score
0.610
QV
Strategy Eligibility
1 of 23 passing
OS Composite
Trending Value
Quality × Value
QV 0.610
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
61.0%ile
P/B
2.4×
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
39.00000000
/100 — 1=cheapest
VC2 (Trending Value)
39.00000000
/100
VC3 (Buyback)
39.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
61.0%ile
ROE
-1.966
ROA
-0.865
Net Margin
-2.693
Op Margin
-2.108
GPA
0.087
D/E
0.18
Current
1.82
F-Score
2/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.128
Stability
0.353
lower=better
Accruals
329.931
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.18. Accruals ratio of 329.931 is elevated — earnings quality may be lower than headline numbers suggest. F-Score of 2/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
61.0%ile
Vol 252d
65.7%
Vol 60d
60.8%
↓ Contracting
Max DD 12M
-79.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.74
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
71.5%
Sector Quality %ile
75.4%
P/B z-score
-0.22
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
74.6% avg (1 factors)
Quality
F
20.7% avg (8 factors)
Risk
F
7.1% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.740—1
Value %ile0.610—0
Quality %ile0.610—0
Momentum %ile0.610—0
F-Score2.000—1
Confidence0.727—1
Volatility0.657—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
2.41
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-196.6%
Return on Assets
-86.5%
Net Margin
-269.3%
Operating Margin
-210.8%
Gross Profit / Assets
Novy-Marx GPA
8.7%
Debt / Equity
0.18
Current Ratio
1.82
Accruals Ratio
(NI-OCF)/Assets — lower=better
329.931
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
12.8%
Earnings Stability (CV)
Lower = more stable
0.353
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
2
Dividend Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
39
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
39
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
39
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity